Catalyst Pharmaceuticals hits FDA snag for Shkreli-esque drug
The company is in trials for its drug, Firdapse, that treats LEMS. However, a generic form of that drug's been in use for decades.
The company is in trials for its drug, Firdapse, that treats LEMS. However, a generic form of that drug's been in use for decades.